Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01797302 · ClinicalTrials.gov registry record · NA

Vitamin D and Vascular Health in Children

A NA study of Obesity and Vitamin D Deficiency, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT01797302: Completed NA study of Obesity and Vitamin D Deficiency, sponsored by University of Pittsburgh.

NCT01797302 is a NA study of Obesity and Vitamin D Deficiency that has completed, run by University of Pittsburgh. The registered enrollment target is 225 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01797302, a NA study of Obesity and Vitamin D Deficiency, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

In this study, we will test the central hypothesis that enhancement of vitamin D status in obese and overweight children will improve their vascular health and their cardiovascular disease (CVD) and metabolic syndrome risk profile.

Primary Outcome

Brachial artery flow-mediated dilation percentage is a measure of endothelial function. FMD percentage calculation is based on baseline brachial artery diameter(brachialADbase) and change in brachial artery diameter (brachialADchange) during post-occlusive reactive hyperemia. FMD% was determined using the formula (brachialADchange/brachialADbase) x 100.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3

Study Locations (1)

Pennsylvania

  • Primary Care Center, Children's Hospital of Pittsburgh of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2013-08
Est. Completion 2018-08-13
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT01797302 record still lists

NCT01797302 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 is the first listed.

NCT01797302 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01797302 about?

NCT01797302 is a clinical study titled "Vitamin D and Vascular Health in Children". In this study, we will test the central hypothesis that enhancement of vitamin D status in obese and overweight children will improve their vascular health and their cardiovascular disease (CVD) and metabolic syndrome risk profile.

What is the current status of trial NCT01797302?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2013-08. Estimated completion is 2018-08-13.

What conditions does trial NCT01797302 study?

This clinical trial studies the following conditions: Obesity, Vitamin D Deficiency.

What interventions are being tested in trial NCT01797302?

The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01797302?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01797302 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01797302's enrollment target sits among peer trials

225 287th of 1053 higher than 763 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01797302, the US trial registry maintained by the National Library of Medicine. NCT01797302 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.